<http://www.wikidata.org/entity/Q90766325>	<http://www.wikidata.org/prop/direct/P2093>	"Sophie Li" .
<http://www.wikidata.org/entity/Q90766325>	<http://www.wikidata.org/prop/direct/P2093>	"Michel Streuli" .
<http://www.wikidata.org/entity/Q90766325>	<http://schema.org/name>	"Biophysical and Immunological Characterization and In Vivo Pharmacokinetics and Toxicology in Non-Human Primates of the Anti-PD-1 Antibody Pembrolizumab"@en .
<http://www.wikidata.org/entity/Q90766325>	<http://www.wikidata.org/prop/P1476>	<http://www.wikidata.org/entity/statement/Q90766325-3F903A3F-C331-4CBB-9489-87D654D82A74> .
<http://www.wikidata.org/entity/Q90766325>	<http://www.wikidata.org/prop/direct/P2093>	"Constance Cullen" .
<http://www.wikidata.org/entity/Q90766325>	<http://schema.org/description>	"article scientifique publi\u00E9 en 2020"@fr .
<http://www.wikidata.org/entity/Q90766325>	<http://www.w3.org/2004/02/skos/core#prefLabel>	"Biophysical and Immunological Characterization and In Vivo Pharmacokinetics and Toxicology in Non-Human Primates of the Anti-PD-1 Antibody Pembrolizumab"@en .
<http://www.wikidata.org/entity/Q90766325>	<http://www.wikidata.org/prop/direct-normalized/P356>	<http://dx.doi.org/10.1158/1535-7163.MCT-19-0774> .
<http://www.wikidata.org/entity/Q90766325>	<http://www.wikidata.org/prop/P921>	<http://www.wikidata.org/entity/statement/Q90766325-0C859ABB-E14D-4D84-A35D-B41C188E239A> .
<http://www.wikidata.org/entity/Q90766325>	<http://www.wikidata.org/prop/direct/P50>	<http://www.wikidata.org/entity/Q90766318> .
<http://www.wikidata.org/entity/Q90766325>	<http://schema.org/description>	"wetenschappelijk artikel"@nl .
<http://www.wikidata.org/entity/Q90766325>	<http://www.wikidata.org/prop/direct/P50>	<http://www.wikidata.org/entity/Q90766322> .
<http://www.wikidata.org/entity/Q90766325>	<http://www.wikidata.org/prop/direct/P50>	<http://www.wikidata.org/entity/Q90766312> .
<http://www.wikidata.org/entity/Q90766325>	<http://www.wikidata.org/prop/direct/P50>	<http://www.wikidata.org/entity/Q90766314> .
<http://www.wikidata.org/entity/Q90766325>	<http://www.wikidata.org/prop/direct/P2093>	"Danuta Herzyk" .
<http://www.wikidata.org/entity/Q90766325>	<http://www.wikidata.org/prop/direct/P2093>	"John Dulos" .
<http://www.wikidata.org/entity/Q90766325>	<http://www.wikidata.org/prop/P2093>	<http://www.wikidata.org/entity/statement/Q90766325-056CC75F-0520-43AB-B8D7-E6E94F381492> .
<http://www.wikidata.org/entity/Q90766325>	<http://www.wikidata.org/prop/P2093>	<http://www.wikidata.org/entity/statement/Q90766325-2E79550E-2A93-45C2-9E71-73113160BC17> .
<http://www.wikidata.org/entity/Q90766325>	<http://www.wikidata.org/prop/direct/P2093>	"Mark Hsieh" .
<http://www.wikidata.org/entity/Q90766325>	<http://www.wikidata.org/prop/P577>	<http://www.wikidata.org/entity/statement/Q90766325-41C914F6-B20E-4D4E-B6A7-1F676072F1F6> .
<http://www.wikidata.org/entity/Q90766325>	<http://www.wikidata.org/prop/direct/P2093>	"Beth Hutchins" .
<http://www.wikidata.org/entity/Q90766325>	<http://www.wikidata.org/prop/P2093>	<http://www.wikidata.org/entity/statement/Q90766325-3E8FBF56-145F-45DB-BC98-F9BE2875F941> .
<http://www.wikidata.org/entity/Q90766325>	<http://www.wikidata.org/prop/P698>	<http://www.wikidata.org/entity/statement/Q90766325-0EA17EA1-A062-4118-91D1-D6CA2740FBE5> .
<http://www.wikidata.org/entity/Q90766325>	<http://www.wikidata.org/prop/direct/P50>	<http://www.wikidata.org/entity/Q59760175> .
<http://www.wikidata.org/entity/Q90766325>	<http://www.wikidata.org/prop/P2093>	<http://www.wikidata.org/entity/statement/Q90766325-28C35707-CFC6-484D-A3CE-8EEEC427AE93> .
<http://www.wikidata.org/entity/Q90766325>	<http://www.wikidata.org/prop/direct/P2093>	"Svetlana Sadekova" .
<http://www.wikidata.org/entity/Q90766325>	<http://www.wikidata.org/prop/direct/P2093>	"George Soder" .
<http://www.wikidata.org/entity/Q90766325>	<http://www.wikidata.org/prop/P50>	<http://www.wikidata.org/entity/statement/Q90766325-29227867-D630-4E44-BFF5-CDBA99779E00> .
<http://www.wikidata.org/entity/Q90766325>	<http://www.wikidata.org/prop/P2093>	<http://www.wikidata.org/entity/statement/Q90766325-4800951D-395C-491A-A06C-F28E0948B6EF> .
<http://www.wikidata.org/entity/Q90766325>	<http://www.wikidata.org/prop/direct/P2093>	"Julie Lee" .
<http://www.wikidata.org/entity/Q90766325>	<http://schema.org/description>	"\u043D\u0430\u0443\u043A\u043E\u0432\u0430 \u0441\u0442\u0430\u0442\u0442\u044F, \u043E\u043F\u0443\u0431\u043B\u0456\u043A\u043E\u0432\u0430\u043D\u0430 30 \u0431\u0435\u0440\u0435\u0437\u043D\u044F 2020"@uk .
<http://www.wikidata.org/entity/Q90766325>	<http://www.wikidata.org/prop/P2093>	<http://www.wikidata.org/entity/statement/Q90766325-41552876-303F-47BB-815C-3ACAB2A55E03> .
<http://www.wikidata.org/entity/Q90766325>	<http://www.w3.org/2000/01/rdf-schema#label>	"Biophysical and Immunological Characterization and In Vivo Pharmacokinetics and Toxicology in Non-Human Primates of the Anti-PD-1 Antibody Pembrolizumab"@nl .
<http://www.wikidata.org/entity/Q90766325>	<http://www.wikidata.org/prop/direct/P50>	<http://www.wikidata.org/entity/Q57457778> .
<http://www.wikidata.org/entity/Q90766325>	<http://www.wikidata.org/prop/direct/P2093>	"Frederique M Poulet" .
<http://www.wikidata.org/entity/Q90766325>	<http://www.wikidata.org/prop/direct/P1433>	<http://www.wikidata.org/entity/Q2363144> .
<http://www.wikidata.org/entity/Q90766325>	<http://www.wikidata.org/prop/direct-normalized/P698>	<http://rdf.ncbi.nlm.nih.gov/pubchem/reference/32229606> .
<http://www.wikidata.org/entity/Q90766325>	<http://www.wikidata.org/prop/P1433>	<http://www.wikidata.org/entity/statement/Q90766325-82073E96-DD50-4AE5-B87D-34BDDD78206E> .
<http://www.wikidata.org/entity/Q90766325>	<http://www.wikidata.org/prop/P2093>	<http://www.wikidata.org/entity/statement/Q90766325-5AB8D2C0-6001-4E2F-ABC2-67AF349CD042> .
<http://www.wikidata.org/entity/Q90766325>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://wikiba.se/ontology#Item> .
<http://www.wikidata.org/entity/Q90766325>	<http://www.wikidata.org/prop/P2093>	<http://www.wikidata.org/entity/statement/Q90766325-8246F773-D43F-4475-9461-9A0013ABE3A8> .
<http://www.wikidata.org/entity/Q90766325>	<http://www.w3.org/2000/01/rdf-schema#label>	"Biophysical and Immunological Characterization and In Vivo Pharmacokinetics and Toxicology in Non-Human Primates of the Anti-PD-1 Antibody Pembrolizumab"@en .
<http://www.wikidata.org/entity/Q90766325>	<http://www.wikidata.org/prop/direct/P2093>	"Soonmo Peter Kang" .
<http://www.wikidata.org/entity/Q90766325>	<http://www.wikidata.org/prop/P2093>	<http://www.wikidata.org/entity/statement/Q90766325-6BA1FBD1-2E11-4D43-B623-A82F6689255A> .
<http://www.wikidata.org/entity/Q90766325>	<http://www.wikidata.org/prop/direct/P2093>	"Robert A Kastelein" .
<http://www.wikidata.org/entity/Q90766325>	<http://www.wikidata.org/prop/P2093>	<http://www.wikidata.org/entity/statement/Q90766325-79CE5EDA-A725-4165-BF88-17810993B591> .
<http://www.wikidata.org/entity/Q90766325>	<http://www.wikidata.org/prop/P2093>	<http://www.wikidata.org/entity/statement/Q90766325-9B3B2088-3D68-42F8-B546-1D618F1C5685> .
<http://www.wikidata.org/entity/Q90766325>	<http://www.wikidata.org/prop/direct/P2093>	"Christine L Andrews" .
<http://www.wikidata.org/entity/Q90766325>	<http://www.wikidata.org/prop/P2093>	<http://www.wikidata.org/entity/statement/Q90766325-9CF884AA-0AFA-44B7-8694-D87AD2497642> .
<http://www.wikidata.org/entity/Q90766325>	<http://www.wikidata.org/prop/P50>	<http://www.wikidata.org/entity/statement/Q90766325-920E6E99-1960-4480-9B24-5A9FCA56C078> .
<http://www.wikidata.org/entity/Q90766325>	<http://www.wikidata.org/prop/P2093>	<http://www.wikidata.org/entity/statement/Q90766325-8BC06C83-028C-4FED-8F28-D3AB64E8ABD8> .
<http://www.wikidata.org/entity/Q90766325>	<http://www.wikidata.org/prop/P31>	<http://www.wikidata.org/entity/statement/Q90766325-C0008718-1E94-406C-9046-3E2FB53AB1BE> .
<http://www.wikidata.org/entity/Q90766325>	<http://www.wikidata.org/prop/direct/P2093>	"Aarron Willingham" .
<http://www.wikidata.org/entity/Q90766325>	<http://schema.org/description>	"scientific article published on 30 March 2020"@en .
<http://www.wikidata.org/entity/Q90766325>	<http://www.wikidata.org/prop/direct/P50>	<http://www.wikidata.org/entity/Q57020026> .
<http://www.wikidata.org/entity/Q90766325>	<http://www.wikidata.org/prop/direct/P356>	"10.1158/1535-7163.MCT-19-0774" .
<http://www.wikidata.org/entity/Q90766325>	<http://www.wikidata.org/prop/P2093>	<http://www.wikidata.org/entity/statement/Q90766325-A06A0F2C-5B61-4061-953C-AA8DBA5D5C7A> .
<http://www.wikidata.org/entity/Q90766325>	<http://www.wikidata.org/prop/direct/P1476>	"Biophysical and Immunological Characterization and In Vivo Pharmacokinetics and Toxicology in Non-Human Primates of the Anti-PD-1 Antibody Pembrolizumab"@en .
<http://www.wikidata.org/entity/Q90766325>	<http://www.wikidata.org/prop/P50>	<http://www.wikidata.org/entity/statement/Q90766325-B0DA04D2-9A7B-4459-B347-3D47128F7F76> .
<http://www.wikidata.org/entity/Q90766325>	<http://www.wikidata.org/prop/P2093>	<http://www.wikidata.org/entity/statement/Q90766325-AACEB3D3-069D-4089-9AD3-640E7F66D405> .
<http://www.wikidata.org/entity/Q90766325>	<http://www.wikidata.org/prop/P50>	<http://www.wikidata.org/entity/statement/Q90766325-595ABBEB-DAF1-4A25-9380-30FC4EEF511D> .
<http://www.wikidata.org/entity/Q90766325>	<http://www.wikidata.org/prop/direct/P31>	<http://www.wikidata.org/entity/Q13442814> .
<http://www.wikidata.org/entity/Q90766325>	<http://www.wikidata.org/prop/P2093>	<http://www.wikidata.org/entity/statement/Q90766325-CC65F0BC-29A3-42F6-8E57-6FB1C163095E> .
<http://www.wikidata.org/entity/Q90766325>	<http://www.wikidata.org/prop/P50>	<http://www.wikidata.org/entity/statement/Q90766325-5CEC1BFF-02C9-42CE-BFF4-DFFD74F7770C> .
<http://www.wikidata.org/entity/Q90766325>	<http://www.wikidata.org/prop/P50>	<http://www.wikidata.org/entity/statement/Q90766325-6250829B-F5CB-410B-A6EE-93842F604EAC> .
<http://www.wikidata.org/entity/Q90766325>	<http://www.wikidata.org/prop/P356>	<http://www.wikidata.org/entity/statement/Q90766325-00E2B531-F114-489A-A45F-2238DC344A1B> .
<http://www.wikidata.org/entity/Q90766325>	<http://www.wikidata.org/prop/direct/P2093>	"Hans van Eenennaam" .
<http://www.wikidata.org/entity/Q90766325>	<http://www.wikidata.org/prop/P2093>	<http://www.wikidata.org/entity/statement/Q90766325-F4CEB0C3-AF81-488E-AC02-05CEFEA4DB7B> .
<http://www.wikidata.org/entity/Q90766325>	<http://www.wikidata.org/prop/P2093>	<http://www.wikidata.org/entity/statement/Q90766325-F7A92078-982A-4E06-9B13-DF38CB27A8BD> .
<http://www.wikidata.org/entity/Q90766325>	<http://www.wikidata.org/prop/direct/P698>	"32229606" .
<http://www.wikidata.org/entity/Q90766325>	<http://www.wikidata.org/prop/direct/P577>	"2020-03-30T00:00:00Z"^^<http://www.w3.org/2001/XMLSchema#dateTime> .
<http://www.wikidata.org/entity/Q90766325>	<http://schema.org/description>	"art\u00EDculu cient\u00EDficu espubliz\u00E1u en marzu de 2020"@ast .
<http://www.wikidata.org/entity/Q90766325>	<http://www.wikidata.org/prop/direct/P2093>	"Ying Yu" .
<http://www.wikidata.org/entity/Q90766325>	<http://www.wikidata.org/prop/P50>	<http://www.wikidata.org/entity/statement/Q90766325-D0E850B5-0294-4C73-A585-41D2BDBA347F> .
<http://www.wikidata.org/entity/Q90766325>	<http://www.wikidata.org/prop/P50>	<http://www.wikidata.org/entity/statement/Q90766325-E2E5957A-3BD5-4680-A1AE-52C381959BAC> .
<http://www.wikidata.org/entity/Q90766325>	<http://www.wikidata.org/prop/direct/P50>	<http://www.wikidata.org/entity/Q81008973> .
<http://www.wikidata.org/entity/Q90766325>	<http://www.wikidata.org/prop/P50>	<http://www.wikidata.org/entity/statement/Q90766325-F3D99C24-4DF4-4048-AF29-F407E0B9FEC5> .
<http://www.wikidata.org/entity/Q90766325>	<http://schema.org/name>	"Biophysical and Immunological Characterization and In Vivo Pharmacokinetics and Toxicology in Non-Human Primates of the Anti-PD-1 Antibody Pembrolizumab"@nl .
<http://www.wikidata.org/entity/Q90766325>	<http://www.wikidata.org/prop/direct/P2093>	"Dan Malashock" .
<http://www.wikidata.org/entity/Q90766325>	<http://www.w3.org/2004/02/skos/core#prefLabel>	"Biophysical and Immunological Characterization and In Vivo Pharmacokinetics and Toxicology in Non-Human Primates of the Anti-PD-1 Antibody Pembrolizumab"@nl .
<http://www.wikidata.org/entity/Q90766325>	<http://www.wikidata.org/prop/direct/P921>	<http://www.wikidata.org/entity/Q13896859> .
<http://www.wikidata.org/entity/Q90766325>	<http://www.wikidata.org/prop/direct/P50>	<http://www.wikidata.org/entity/Q90266830> .